本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Magenta Therapeutics Inc.

11.19
0.0000
成交量:- -
成交額:26.88萬
市值:4,224.34萬
市盈率:-0.61
高:11.19
開:11.19
低:11.19
收:11.19
52周最高:35.49
52周最低:5.14
股本:377.39萬
流通股本:210.24萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-18.2297
每股收益(LYR):-20.6054
淨資產收益率:-65.34%
總資產收益率:-28.85%
市淨率:0.57
市盈率(LYR):-0.54

資料載入中...

2023/09/22

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

SEC問詢函

Form CORRESP - Correspondence
2023/07/17

SEC問詢函

Form CORRESP - Correspondence
2023/06/23

SEC問詢函

Form CORRESP - Correspondence
2023/05/20

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/19

重要事件披露

Form 8-K - Current report
2023/05/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

重要事件披露

8-K - Current report
2023/05/03

企業合併公告

425 - Prospectuses and communications, business combinations
2023/05/01

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]